Pepcid Complete is an over-the-counter drug owned by J And J Consumer Inc. It contains active ingredients such as Calcium Carbonate, Famotidine, and Magnesium Hydroxide. This drug was first authorized for market use on 16 October, 2000 and is available in chewable tablets for oral administration.
The generic version of Pepcid Complete is likely to be released after 26 February, 2022. This is tied to the expiry date of the last patent, US6814978*PED, which pertains to the process for preparing a soft tablet.
Pepcid Complete is primarily used for the treatment of heartburn associated with acid indigestion and sour stomach. The active ingredients work together to neutralize acid in the stomach and decrease the production of stomach acid triggered by eating or drinking certain foods and beverages.
Pepcid Complete has a total of 1 authorized drug patent in the United States. The last patent, US6814978*PED, expired on 26 February, 2022. This has paved the way for the release of the Pepcid Complete generic version. Below are the details of the patent: